Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions

NCT01862900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Lung Metastases
Liver Metastases

Interventions

BIOLOGICAL: MEDI6469

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]
[object Object]